Global Immunoassay CDMO Market Research Report 2026(Status and Outlook)

May 2026 | 147 pages | ID: G532FA3305A4EN
Bosson Research

US$ 3,200.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Immunoassay CDMOs (Contract Development and Manufacturing Organizations) are specialized service providers that support diagnostic and biopharmaceutical companies in the development and manufacturing of immunoassay-based products. These services typically include assay design, reagent formulation, kit assembly, vial/bottle filling, labeling, QC/QA testing, and cGMP-compliant production. Immunoassay CDMOs operate across various platforms such as ELISA (enzyme-linked immunosorbent assay), CLIA (chemiluminescent immunoassay), and LFA (lateral flow assay). As demand grows for rapid, accurate, and scalable diagnostic solutions, immunoassay CDMOs play a pivotal role in accelerating time-to-market and ensuring regulatory compliance for global distribution.

The global Immunoassay CDMO market size was estimated at USD 9986.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 8.90% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Immunoassay CDMO market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Immunoassay CDMO market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Immunoassay CDMO market.

Global Immunoassay CDMO Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

  • Firalis Molecular Precision
  • ProBio
  • Sanner GmbH
  • Biopharma Group
  • ZeptoMetrix
  • Stevanato Group
  • Shenzhen AIVD Biotechnology
  • Thermo Fisher Scientific
  • Pharmigene
  • Molex Company
  • Argonaut Manufacturing Services
  • Merck KGaA
  • InBios International
  • Fujirebio Holdings

Market Segmentation (by Type)

  • ELISA
  • CLIA
  • LFA
  • Other

Market Segmentation (by Application)

  • Tumor markers
  • Hormone
  • Infectious diseases
  • Other

Geographic Segmentation

  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Immunoassay CDMO Market

Overview of the regional outlook of the Immunoassay CDMO Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Immunoassay CDMO Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Immunoassay CDMO, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Immunoassay CDMO
1.2 Key Market Segments
  1.2.1 Immunoassay CDMO Segment by Type
  1.2.2 Immunoassay CDMO Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 IMMUNOASSAY CDMO MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Immunoassay CDMO Market Size (M USD) Estimates and Forecasts (2020-2035)
  2.1.2 Global Immunoassay CDMO Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 IMMUNOASSAY CDMO MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Immunoassay CDMO Product Life Cycle
3.3 Global Immunoassay CDMO Sales by Manufacturers (2020-2025)
3.4 Global Immunoassay CDMO Revenue Market Share by Manufacturers (2020-2025)
3.5 Immunoassay CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Immunoassay CDMO Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Immunoassay CDMO Market Competitive Situation and Trends
  3.8.1 Immunoassay CDMO Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Immunoassay CDMO Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 IMMUNOASSAY CDMO INDUSTRY CHAIN ANALYSIS

4.1 Immunoassay CDMO Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF IMMUNOASSAY CDMO MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Immunoassay CDMO Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy – April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Immunoassay CDMO Market
5.7 ESG Ratings of Leading Companies

6 IMMUNOASSAY CDMO MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Immunoassay CDMO Sales Market Share by Type (2020-2025)
6.3 Global Immunoassay CDMO Market Size by Type (2020-2025)
6.4 Global Immunoassay CDMO Price by Type (2020-2025)

7 IMMUNOASSAY CDMO MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Immunoassay CDMO Market Sales by Application (2020-2025)
7.3 Global Immunoassay CDMO Market Size (M USD) by Application (2020-2025)
7.4 Global Immunoassay CDMO Sales Growth Rate by Application (2020-2025)

8 IMMUNOASSAY CDMO MARKET SALES BY REGION

8.1 Global Immunoassay CDMO Sales by Region
  8.1.1 Global Immunoassay CDMO Sales by Region
  8.1.2 Global Immunoassay CDMO Sales Market Share by Region
8.2 Global Immunoassay CDMO Market Size by Region
  8.2.1 Global Immunoassay CDMO Market Size by Region
  8.2.2 Global Immunoassay CDMO Market Size by Region
8.3 North America
  8.3.1 North America Immunoassay CDMO Sales by Country
  8.3.2 North America Immunoassay CDMO Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Immunoassay CDMO Sales by Country
  8.4.2 Europe Immunoassay CDMO Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Immunoassay CDMO Sales by Region
  8.5.2 Asia Pacific Immunoassay CDMO Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Immunoassay CDMO Sales by Country
  8.6.2 South America Immunoassay CDMO Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Immunoassay CDMO Sales by Region
  8.7.2 Middle East and Africa Immunoassay CDMO Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 IMMUNOASSAY CDMO MARKET PRODUCTION BY REGION

9.1 Global Production of Immunoassay CDMO by Region(2020-2025)
9.2 Global Immunoassay CDMO Revenue Market Share by Region (2020-2025)
9.3 Global Immunoassay CDMO Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Immunoassay CDMO Production
  9.4.1 North America Immunoassay CDMO Production Growth Rate (2020-2025)
  9.4.2 North America Immunoassay CDMO Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Immunoassay CDMO Production
  9.5.1 Europe Immunoassay CDMO Production Growth Rate (2020-2025)
  9.5.2 Europe Immunoassay CDMO Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Immunoassay CDMO Production (2020-2025)
  9.6.1 Japan Immunoassay CDMO Production Growth Rate (2020-2025)
  9.6.2 Japan Immunoassay CDMO Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Immunoassay CDMO Production (2020-2025)
  9.7.1 China Immunoassay CDMO Production Growth Rate (2020-2025)
  9.7.2 China Immunoassay CDMO Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Firalis Molecular Precision
  10.1.1 Firalis Molecular Precision Basic Information
  10.1.2 Firalis Molecular Precision Immunoassay CDMO Product Overview
  10.1.3 Firalis Molecular Precision Immunoassay CDMO Product Market Performance
  10.1.4 Firalis Molecular Precision Business Overview
  10.1.5 Firalis Molecular Precision SWOT Analysis
  10.1.6 Firalis Molecular Precision Recent Developments
10.2 ProBio
  10.2.1 ProBio Basic Information
  10.2.2 ProBio Immunoassay CDMO Product Overview
  10.2.3 ProBio Immunoassay CDMO Product Market Performance
  10.2.4 ProBio Business Overview
  10.2.5 ProBio SWOT Analysis
  10.2.6 ProBio Recent Developments
10.3 Sanner GmbH
  10.3.1 Sanner GmbH Basic Information
  10.3.2 Sanner GmbH Immunoassay CDMO Product Overview
  10.3.3 Sanner GmbH Immunoassay CDMO Product Market Performance
  10.3.4 Sanner GmbH Business Overview
  10.3.5 Sanner GmbH SWOT Analysis
  10.3.6 Sanner GmbH Recent Developments
10.4 Biopharma Group
  10.4.1 Biopharma Group Basic Information
  10.4.2 Biopharma Group Immunoassay CDMO Product Overview
  10.4.3 Biopharma Group Immunoassay CDMO Product Market Performance
  10.4.4 Biopharma Group Business Overview
  10.4.5 Biopharma Group Recent Developments
10.5 ZeptoMetrix
  10.5.1 ZeptoMetrix Basic Information
  10.5.2 ZeptoMetrix Immunoassay CDMO Product Overview
  10.5.3 ZeptoMetrix Immunoassay CDMO Product Market Performance
  10.5.4 ZeptoMetrix Business Overview
  10.5.5 ZeptoMetrix Recent Developments
10.6 Stevanato Group
  10.6.1 Stevanato Group Basic Information
  10.6.2 Stevanato Group Immunoassay CDMO Product Overview
  10.6.3 Stevanato Group Immunoassay CDMO Product Market Performance
  10.6.4 Stevanato Group Business Overview
  10.6.5 Stevanato Group Recent Developments
10.7 Shenzhen AIVD Biotechnology
  10.7.1 Shenzhen AIVD Biotechnology Basic Information
  10.7.2 Shenzhen AIVD Biotechnology Immunoassay CDMO Product Overview
  10.7.3 Shenzhen AIVD Biotechnology Immunoassay CDMO Product Market Performance
  10.7.4 Shenzhen AIVD Biotechnology Business Overview
  10.7.5 Shenzhen AIVD Biotechnology Recent Developments
10.8 Thermo Fisher Scientific
  10.8.1 Thermo Fisher Scientific Basic Information
  10.8.2 Thermo Fisher Scientific Immunoassay CDMO Product Overview
  10.8.3 Thermo Fisher Scientific Immunoassay CDMO Product Market Performance
  10.8.4 Thermo Fisher Scientific Business Overview
  10.8.5 Thermo Fisher Scientific Recent Developments
10.9 Pharmigene
  10.9.1 Pharmigene Basic Information
  10.9.2 Pharmigene Immunoassay CDMO Product Overview
  10.9.3 Pharmigene Immunoassay CDMO Product Market Performance
  10.9.4 Pharmigene Business Overview
  10.9.5 Pharmigene Recent Developments
10.10 Molex Company
  10.10.1 Molex Company Basic Information
  10.10.2 Molex Company Immunoassay CDMO Product Overview
  10.10.3 Molex Company Immunoassay CDMO Product Market Performance
  10.10.4 Molex Company Business Overview
  10.10.5 Molex Company Recent Developments
10.11 Argonaut Manufacturing Services
  10.11.1 Argonaut Manufacturing Services Basic Information
  10.11.2 Argonaut Manufacturing Services Immunoassay CDMO Product Overview
  10.11.3 Argonaut Manufacturing Services Immunoassay CDMO Product Market Performance
  10.11.4 Argonaut Manufacturing Services Business Overview
  10.11.5 Argonaut Manufacturing Services Recent Developments
10.12 Merck KGaA
  10.12.1 Merck KGaA Basic Information
  10.12.2 Merck KGaA Immunoassay CDMO Product Overview
  10.12.3 Merck KGaA Immunoassay CDMO Product Market Performance
  10.12.4 Merck KGaA Business Overview
  10.12.5 Merck KGaA Recent Developments
10.13 InBios International
  10.13.1 InBios International Basic Information
  10.13.2 InBios International Immunoassay CDMO Product Overview
  10.13.3 InBios International Immunoassay CDMO Product Market Performance
  10.13.4 InBios International Business Overview
  10.13.5 InBios International Recent Developments
10.14 Fujirebio Holdings
  10.14.1 Fujirebio Holdings Basic Information
  10.14.2 Fujirebio Holdings Immunoassay CDMO Product Overview
  10.14.3 Fujirebio Holdings Immunoassay CDMO Product Market Performance
  10.14.4 Fujirebio Holdings Business Overview
  10.14.5 Fujirebio Holdings Recent Developments

11 IMMUNOASSAY CDMO MARKET FORECAST BY REGION

11.1 Global Immunoassay CDMO Market Size Forecast
11.2 Global Immunoassay CDMO Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Immunoassay CDMO Market Size Forecast by Country
  11.2.3 Asia Pacific Immunoassay CDMO Market Size Forecast by Region
  11.2.4 South America Immunoassay CDMO Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Immunoassay CDMO by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

12.1 Global Immunoassay CDMO Market Forecast by Type (2026-2035)
  12.1.1 Global Forecasted Sales of Immunoassay CDMO by Type (2026-2035)
  12.1.2 Global Immunoassay CDMO Market Size Forecast by Type (2026-2035)
  12.1.3 Global Forecasted Price of Immunoassay CDMO by Type (2026-2035)
12.2 Global Immunoassay CDMO Market Forecast by Application (2026-2035)
  12.2.1 Global Immunoassay CDMO Sales (K Units) Forecast by Application
  12.2.2 Global Immunoassay CDMO Market Size (M USD) Forecast by Application (2026-2035)

13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Immunoassay CDMO Market Size by Type (M USD)
Table 4. Global Immunoassay CDMO Market Size by Application
Table 5. Immunoassay CDMO Market Size Comparison by Region (M USD)
Table 6. Global Immunoassay CDMO Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Immunoassay CDMO Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Immunoassay CDMO Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Immunoassay CDMO Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunoassay CDMO as of 2025)
Table 11. Global Market Immunoassay CDMO Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Immunoassay CDMO Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Immunoassay CDMO Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Immunoassay CDMO Sales by Type (K Units)
Table 27. Global Immunoassay CDMO Market Size by Type (M USD)
Table 28. Global Immunoassay CDMO Sales (K Units) by Type (2020-2025)
Table 29. Global Immunoassay CDMO Sales Market Share by Type (2020-2025)
Table 30. Global Immunoassay CDMO Market Size (M USD) by Type (2020-2025)
Table 31. Global Immunoassay CDMO Market Share by Type (2020-2025)
Table 32. Global Immunoassay CDMO Price (USD/Unit) by Type (2020-2025)
Table 33. Global Immunoassay CDMO Sales (K Units) by Application
Table 34. Global Immunoassay CDMO Market Size by Application
Table 35. Global Immunoassay CDMO Sales by Application (2020-2025) & (K Units)
Table 36. Global Immunoassay CDMO Sales Market Share by Application (2020-2025)
Table 37. Global Immunoassay CDMO Market Size by Application (2020-2025) & (M USD)
Table 38. Global Immunoassay CDMO Market Share by Application (2020-2025)
Table 39. Global Immunoassay CDMO Sales Growth Rate by Application (2020-2025)
Table 40. Global Immunoassay CDMO Sales by Region (2020-2025) & (K Units)
Table 41. Global Immunoassay CDMO Sales Market Share by Region (2020-2025)
Table 42. Global Immunoassay CDMO Market Size by Region (2020-2025) & (M USD)
Table 43. Global Immunoassay CDMO Market Size by Region (2020-2025)
Table 44. North America Immunoassay CDMO Sales by Country (2020-2025) & (K Units)
Table 45. North America Immunoassay CDMO Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Immunoassay CDMO Sales by Country (2020-2025) & (K Units)
Table 47. Europe Immunoassay CDMO Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Immunoassay CDMO Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Immunoassay CDMO Market Size by Region (2020-2025) & (M USD)
Table 50. South America Immunoassay CDMO Sales by Country (2020-2025) & (K Units)
Table 51. South America Immunoassay CDMO Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Immunoassay CDMO Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Immunoassay CDMO Market Size by Region (2020-2025) & (M USD)
Table 54. Global Immunoassay CDMO Production (K Units) by Region(2020-2025)
Table 55. Global Immunoassay CDMO Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Immunoassay CDMO Revenue Market Share by Region (2020-2025)
Table 57. Global Immunoassay CDMO Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Immunoassay CDMO Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Immunoassay CDMO Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Immunoassay CDMO Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Immunoassay CDMO Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Firalis Molecular Precision Basic Information
Table 63. Firalis Molecular Precision Immunoassay CDMO Product Overview
Table 64. Firalis Molecular Precision Immunoassay CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Firalis Molecular Precision Business Overview
Table 66. Firalis Molecular Precision SWOT Analysis
Table 67. Firalis Molecular Precision Recent Developments
Table 68. ProBio Basic Information
Table 69. ProBio Immunoassay CDMO Product Overview
Table 70. ProBio Immunoassay CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. ProBio Business Overview
Table 72. ProBio SWOT Analysis
Table 73. ProBio Recent Developments
Table 74. Sanner GmbH Basic Information
Table 75. Sanner GmbH Immunoassay CDMO Product Overview
Table 76. Sanner GmbH Immunoassay CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Sanner GmbH Business Overview
Table 78. Sanner GmbH SWOT Analysis
Table 79. Sanner GmbH Recent Developments
Table 80. Biopharma Group Basic Information
Table 81. Biopharma Group Immunoassay CDMO Product Overview
Table 82. Biopharma Group Immunoassay CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Biopharma Group Business Overview
Table 84. Biopharma Group Recent Developments
Table 85. ZeptoMetrix Basic Information
Table 86. ZeptoMetrix Immunoassay CDMO Product Overview
Table 87. ZeptoMetrix Immunoassay CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. ZeptoMetrix Business Overview
Table 89. ZeptoMetrix Recent Developments
Table 90. Stevanato Group Basic Information
Table 91. Stevanato Group Immunoassay CDMO Product Overview
Table 92. Stevanato Group Immunoassay CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Stevanato Group Business Overview
Table 94. Stevanato Group Recent Developments
Table 95. Shenzhen AIVD Biotechnology Basic Information
Table 96. Shenzhen AIVD Biotechnology Immunoassay CDMO Product Overview
Table 97. Shenzhen AIVD Biotechnology Immunoassay CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Shenzhen AIVD Biotechnology Business Overview
Table 99. Shenzhen AIVD Biotechnology Recent Developments
Table 100. Thermo Fisher Scientific Basic Information
Table 101. Thermo Fisher Scientific Immunoassay CDMO Product Overview
Table 102. Thermo Fisher Scientific Immunoassay CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Thermo Fisher Scientific Business Overview
Table 104. Thermo Fisher Scientific Recent Developments
Table 105. Pharmigene Basic Information
Table 106. Pharmigene Immunoassay CDMO Product Overview
Table 107. Pharmigene Immunoassay CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Pharmigene Business Overview
Table 109. Pharmigene Recent Developments
Table 110. Molex Company Basic Information
Table 111. Molex Company Immunoassay CDMO Product Overview
Table 112. Molex Company Immunoassay CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Molex Company Business Overview
Table 114. Molex Company Recent Developments
Table 115. Argonaut Manufacturing Services Basic Information
Table 116. Argonaut Manufacturing Services Immunoassay CDMO Product Overview
Table 117. Argonaut Manufacturing Services Immunoassay CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Argonaut Manufacturing Services Business Overview
Table 119. Argonaut Manufacturing Services Recent Developments
Table 120. Merck KGaA Basic Information
Table 121. Merck KGaA Immunoassay CDMO Product Overview
Table 122. Merck KGaA Immunoassay CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Merck KGaA Business Overview
Table 124. Merck KGaA Recent Developments
Table 125. InBios International Basic Information
Table 126. InBios International Immunoassay CDMO Product Overview
Table 127. InBios International Immunoassay CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. InBios International Business Overview
Table 129. InBios International Recent Developments
Table 130. Fujirebio Holdings Basic Information
Table 131. Fujirebio Holdings Immunoassay CDMO Product Overview
Table 132. Fujirebio Holdings Immunoassay CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Fujirebio Holdings Business Overview
Table 134. Fujirebio Holdings Recent Developments
Table 135. Global Immunoassay CDMO Sales Forecast by Region (2026-2035) & (K Units)
Table 136. Global Immunoassay CDMO Market Size Forecast by Region (2026-2035) & (M USD)
Table 137. North America Immunoassay CDMO Sales Forecast by Country (2026-2035) & (K Units)
Table 138. North America Immunoassay CDMO Market Size Forecast by Country (2026-2035) & (M USD)
Table 139. Europe Immunoassay CDMO Sales Forecast by Country (2026-2035) & (K Units)
Table 140. Europe Immunoassay CDMO Market Size Forecast by Country (2026-2035) & (M USD)
Table 141. Asia Pacific Immunoassay CDMO Sales Forecast by Region (2026-2035) & (K Units)
Table 142. Asia Pacific Immunoassay CDMO Market Size Forecast by Region (2026-2035) & (M USD)
Table 143. South America Immunoassay CDMO Sales Forecast by Country (2026-2035) & (K Units)
Table 144. South America Immunoassay CDMO Market Size Forecast by Country (2026-2035) & (M USD)
Table 145. Middle East and Africa Immunoassay CDMO Sales Forecast by Country (2026-2035) & (Units)
Table 146. Middle East and Africa Immunoassay CDMO Market Size Forecast by Country (2026-2035) & (M USD)
Table 147. Global Immunoassay CDMO Sales Forecast by Type (2026-2035) & (K Units)
Table 148. Global Immunoassay CDMO Market Size Forecast by Type (2026-2035) & (M USD)
Table 149. Global Immunoassay CDMO Price Forecast by Type (2026-2035) & (USD/Unit)
Table 150. Global Immunoassay CDMO Sales (K Units) Forecast by Application (2026-2035)
Table 151. Global Immunoassay CDMO Market Size Forecast by Application (2026-2035) & (M USD)

LIST OF FIGURES

Figure 1. Product Picture of Immunoassay CDMO
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Immunoassay CDMO Market Size (M USD), 2025-2035
Figure 5. Global Immunoassay CDMO Market Size (M USD) (2020-2035)
Figure 6. Global Immunoassay CDMO Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Immunoassay CDMO Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Immunoassay CDMO Product Life Cycle
Figure 13. Immunoassay CDMO Sales Share by Manufacturers in 2025
Figure 14. Global Immunoassay CDMO Revenue Share by Manufacturers in 2025
Figure 15. Immunoassay CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Immunoassay CDMO Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Immunoassay CDMO Revenue in 2025
Figure 18. Industry Chain Map of Immunoassay CDMO
Figure 19. Global Immunoassay CDMO Market PEST Analysis
Figure 20. Global Immunoassay CDMO Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Immunoassay CDMO Market Share by Type
Figure 27. Sales Market Share of Immunoassay CDMO by Type (2020-2025)
Figure 28. Sales Market Share of Immunoassay CDMO by Type in 2025
Figure 29. Market Share of Immunoassay CDMO by Type (2020-2025)
Figure 30. Market Share of Immunoassay CDMO by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Immunoassay CDMO Market Share by Application
Figure 33. Global Immunoassay CDMO Sales Market Share by Application (2020-2025)
Figure 34. Global Immunoassay CDMO Sales Market Share by Application in 2025
Figure 35. Global Immunoassay CDMO Market Share by Application (2020-2025)
Figure 36. Global Immunoassay CDMO Market Share by Application in 2025
Figure 37. Global Immunoassay CDMO Sales Growth Rate by Application (2020-2025)
Figure 38. Global Immunoassay CDMO Sales Market Share by Region (2020-2025)
Figure 39. Global Immunoassay CDMO Market Size by Region (2020-2025)
Figure 40. North America Immunoassay CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Immunoassay CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Immunoassay CDMO Sales Market Share by Country in 2024
Figure 43. North America Immunoassay CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Immunoassay CDMO Market Size by Country in 2024
Figure 45. U.S. Immunoassay CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Immunoassay CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Immunoassay CDMO Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Immunoassay CDMO Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Immunoassay CDMO Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Immunoassay CDMO Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Immunoassay CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Immunoassay CDMO Sales Market Share by Country in 2024
Figure 53. Europe Immunoassay CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Immunoassay CDMO Market Size by Country in 2024
Figure 55. Germany Immunoassay CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Immunoassay CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Immunoassay CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Immunoassay CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Immunoassay CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Immunoassay CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Immunoassay CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Immunoassay CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Immunoassay CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Immunoassay CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Immunoassay CDMO Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Immunoassay CDMO Sales Market Share by Region in 2024
Figure 67. Asia Pacific Immunoassay CDMO Market Size by Region in 2024
Figure 68. China Immunoassay CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Immunoassay CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Immunoassay CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Immunoassay CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Immunoassay CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Immunoassay CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Immunoassay CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Immunoassay CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Immunoassay CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Immunoassay CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Immunoassay CDMO Sales and Growth Rate (K Units)
Figure 79. South America Immunoassay CDMO Sales Market Share by Country in 2024
Figure 80. South America Immunoassay CDMO Market Size and Growth Rate (M USD)
Figure 81. South America Immunoassay CDMO Market Size by Country in 2024
Figure 82. Brazil Immunoassay CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Immunoassay CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Immunoassay CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Immunoassay CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Immunoassay CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Immunoassay CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Immunoassay CDMO Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Immunoassay CDMO Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Immunoassay CDMO Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Immunoassay CDMO Market Size by Region in 2024
Figure 92. Saudi Arabia Immunoassay CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Immunoassay CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Immunoassay CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Immunoassay CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Immunoassay CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Immunoassay CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Immunoassay CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Immunoassay CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Immunoassay CDMO Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Immunoassay CDMO Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Immunoassay CDMO Production Market Share by Region (2020-2025)
Figure 103. North America Immunoassay CDMO Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Immunoassay CDMO Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Immunoassay CDMO Production (K Units) Growth Rate (2020-2025)
Figure 106. China Immunoassay CDMO Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Immunoassay CDMO Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Immunoassay CDMO Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Immunoassay CDMO Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Immunoassay CDMO Market Share Forecast by Type (2026-2035)
Figure 111. Global Immunoassay CDMO Sales Forecast by Application (2026-2035)
Figure 112. Global Immunoassay CDMO Market Share Forecast by Application (2026-2035)